| 标题 |
Phase 1 study of TG4050, an individualized neoantigen vaccine, in patients with newly diagnosed resectable pancreatic cancer |
| 网址 | |
| DOI |
10.1016/annonc/mds378.058
doi
|
| 其它 | *Annals of Oncology* (ESMO Congress 2023 Supplement) |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)